Nanobionic Technology in McLaren's Senna 1st Model in the United States

Published
07/30/2018 by

Technology has been changing peoples' lives and totally transforming industries at the speed of light, and that includes technology in textiles.

Nanobionic Technology is one of the most innovative technologies applied to fabrics around the world. Nanobionic technology is a coating that is applied to athletic apparel, bedding products, everyday apparel as well as footwear and military apparel.

This game-changing technology can be treated on any kind of fabric, including leather and foam products. When Nanobionic technology comes in close contact with the human body, it stimulates local blood flow, increases strength and endurance, thermo-regulates body temperature, boosts energy, reduces free radicals and speeds up the recovery process.

Nanobionic is now very excited to offer their technology in sports cars, and not just in any kind of sports car, but in one of the most exclusive models in the world. On July 17, 2018, the first McLaren Senna in the United States, debuted at the Bloomberg building in Manhattan, New York. McLaren's exclusive Senna model is 1 of 500 models manufactured for special clients.

This first McLaren Senna in the U.S., also has Nanobionic technology applied on the seats. Nanobionic seats offer the benefits of: stimulating local blood flow, increasing energy, comfort and overall wellness of being to the demanding driver and passenger.

The proud owner of the first McLaren Senna model to come to the United States, and to include Nanobionic Technology on the seats, Michael Fux, is one of the most influential car collectors in the world and generous philanthropist. Michael gave an exclusive interview to CNBC's Robert Frank, and many celebrities were in attendance for the presentation of the emerald green Senna, including ABC's TV Host and former NFL superstar, Michael Strahan.

In an interview, Michael Fux said: "I am very happy to have the first McLaren in the world with Nanobionic technology on the seats."

The founder and CEO of Nanobionic, George Psipsikas, in an interview said: "This is an exciting time for Nanobionic technology. We are experiencing tremendous demand for Nanobionic Technology from many different industries and we will soon announce very important partnerships in many different industries that will offer great benefits to the consumers."